McCarney M, Brennan C, Bunting S, Hill S, Hill J
Blackpool Teaching Hospitals NHS Foundation Trust.
University of Central Lancashire.
Int J Adv Pract. 2024 Oct 2;2(4):199-202. doi: 10.12968/ijap.2023.0056.
Greater Trochanteric Pain Syndrome is a broad term employed to characterize lateral hip pain originating from the structures attached to the greater trochanter of the femur. The documented decrease in work participation, elevated levels of pain and dysfunction impeding physical activity, and diminished quality of life align with those observed in individuals with severe hip osteoarthritis. Effectively managing Greater Trochanteric Pain Syndrome can present considerable challenges. Generally, patients with Greater Trochanteric Pain Syndrome tend to respond favourably to conservative management. However, regarding the conservative approach of using corticosteroid injections there is still some debate regarding the specific estimation of effect. A recent systematic review by Wang et al. (2022) was undertaken to explore the effect of corticosteroid injection in the treatment of Greater Trochanteric Pain Syndrome. This commentary seeks to critically assess the methodologies employed in the review conducted by Wang et al. (2022) and provide a broader understanding of the findings in the context of the four pillars of advanced practice; clinical practice, leadership, education and research.
大转子疼痛综合征是一个广义术语,用于描述源自附着于股骨大转子的结构的髋部外侧疼痛。文献记载,工作参与度下降、疼痛和功能障碍程度升高阻碍身体活动以及生活质量下降,这些情况与重度髋骨关节炎患者中观察到的情况一致。有效管理大转子疼痛综合征可能会带来相当大的挑战。一般来说,大转子疼痛综合征患者往往对保守治疗反应良好。然而,关于使用皮质类固醇注射的保守方法,在效果的具体评估方面仍存在一些争议。Wang等人(2022年)最近进行了一项系统综述,以探讨皮质类固醇注射治疗大转子疼痛综合征的效果。本评论旨在批判性地评估Wang等人(2022年)所进行综述中采用的方法,并在高级实践的四个支柱(临床实践、领导力、教育和研究)的背景下更广泛地理解研究结果。